RealVNC mid banner careers
Advertisement: Bradfield Centre mid
Advertisement: Bridge Fibre mid
Barr Ellison Solicitors – commercial property
Mid banner advertisement: BDO
Advertisement: CBM
Advertisement: RSM
RealVNC mid-banner general
ARM Innovation Hub
Advertisement: TTP
Advertisement: Mogrify mid banner
Advertisement: Lynch Wood Park
Advertisement EY mid banner
Advertisement: Wild Knight Vodka
Advertisement Cambridge China Centre
Advertisement: Cambridge Network
30 November, 2012 - 09:34 By News Desk

Gene genies backed with £0.5m from TSB

Kevin Mathews, CEO of Isogenica

Isogenica in Cambridge and Birmingham’s Aston University have secured funding from the Technology Strategy Board (TSB) for a £0.5 million project to develop a gene library assembly technology exclusively licensed to Isogenica.

The cash enables the UK partners to develop a robust, automated manufacturing process for the commercial synthesis of ratio controlled gene libraries using a patent protected methodology invented by Dr Anna Hine and her team at Aston University.

The capability to build high quality libraries has applications in antibody, protein scaffold and peptide discovery, where high integrity libraries can be designed and built that will increase library diversity and maximise the probability of finding good quality leads.

Kevin Mathews, CEO of Isogenica said: “Isogenica has been approached on a number of occasions by customers interested in accessing controlled ratio controlled libraries and for screening libraries using our proprietary CIS Display technology.

“We have an exclusive license to Aston University’s innovative technology and will develop the approach to meet the market needs for rapid, high quality gene libraries and hope to launch this product area within the next six months.”

Add new comment

Newsletter Subscription

Stay informed of the latest news and features